CYTOMEGALOVIRUS (CMV) PREVENTION STRATEGIES IN SEROPOSITIVE KIDNEY TRANSPLANT (KT) RECIPIENTS RECEIVING ANTILYMPHOCYTE INDUCTION THERAPIES: DATA FROM A MULTICENTER COHORT STUDY (THE OPERA STUDY)

被引：0
|
作者：
Aguado, Jose M. [1 ]
Fernandez-Ruiz, Mario [1 ]
Arias, Manuel [2 ]
Campistol, Josep M. [3 ]
机构：
[1] Univ Hosp 12 Octubre, Infect Dis Unit, Madrid, Spain
[2] Univ Hosp Marques de Valdecilla, Dept Nephrol, Santander, Spain
[3] Hosp Clin IDIBAPS, Dept Nephrol & Renal Transplantat, Barcelona, Spain
来源：
TRANSPLANT INTERNATIONAL | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：29 / 29
页数：1
相关论文
共 23 条
  • [1] Epidemiology and Prevention Approaches for Cytomegalovirus (CMV) Disease in CMV-Seropositive Kidney Transplant (KT) Recipients: Results from a Multicenter, Prospective, Cohort Study (OPERA Study)
    Aguado, J.
    Fernandez-Ruiz, M.
    Arias, M.
    Campistol, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 210 - 210
  • [2] Impact of Different Prevention Strategies On the Risk of Cytomegalovirus (CMV) Infection and Disease in Seropositive Kidney Transplant (KT) Recipients
    Aguado, J.
    Fernandez-Ruiz, M.
    Arias, M.
    Campistol, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 765 - 766
  • [3] Impact of Different Prevention Strategies On the Risk of Cytomegalovirus (CMV) Infection and Disease in Seropositive Kidney Transplant (KT) Recipients.
    Aguado, J.
    Fernandez-Ruiz, M.
    Arias, M.
    Campistol, J.
    TRANSPLANTATION, 2014, 98 : 765 - 766
  • [4] A randomized, phase 2 study of ASP0113, a DNA-based vaccine, for the prevention of CMV in CMV-seronegative kidney transplant recipients receiving a kidney from a CMV-seropositive donor
    Vincenti, Flavio
    Budde, Klemens
    Merville, Pierre
    Shihab, Fuad
    Peddi, V. Ram
    Shah, Malay
    Wyburn, Kate
    Cassuto-Viguier, Elisabeth
    Weidemann, Alexander
    Lee, Misun
    Flegel, Teresa
    Erdman, Jay
    Wang, Xuegong
    Lademacher, Christopher
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 (12) : 2945 - 2954
  • [5] Kinetic of the CMV-specific T-cell immune response and CMV infection in CMV-seropositive kidney transplant recipients receiving rabbit anti-thymocyte globulin induction therapy: A pilot study
    Martin-Gandul, Cecilia
    Perez-Romero, Pilar
    Mena-Romo, Damian
    Molina-Ortega, Alejandro
    Gonzalez-Roncero, Francisco M.
    Suner, Marta
    Bernal, Gabriel
    Cordero, Elisa
    TRANSPLANT INFECTIOUS DISEASE, 2018, 20 (03)
  • [6] Avascular Necrosis in Kidney Transplant Recipients: Recent Data from a Cohort Study
    Perrin, P.
    Felten, R.
    Caillard, S.
    Schaeffer, M.
    Moulin, B.
    Javier, R. -M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 667 - 667
  • [7] Secular trends in cytomegalovirus (CMV) risk and outcomes: results from a 10-year longitudinal cohort study in adult kidney transplant recipients
    Perry, Amy
    Soliman, Karim
    Andrade, Erika
    Mesmar, Zaid
    Overstreet, Morgan
    Fulop, Tibor
    Calimlim, Isabel K.
    Harris, Courtney
    Taber, David J.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2025,
  • [8] Cytomegalovirus infections in lung and hematopoietic cell transplant recipients in the Organ Transplant Infection Prevention and Detection Study: A multi-year, multicenter prospective cohort study
    Avery, Robin K.
    Silveira, Fernanda P.
    Benedict, Kaitlin
    Cleveland, Angela A.
    Kauffman, Carol A.
    Schuster, Mindy G.
    Dubberke, Erik R.
    Husain, Shahid
    Paterson, David L.
    Chiller, Tom
    Pappas, Peter
    TRANSPLANT INFECTIOUS DISEASE, 2018, 20 (03)
  • [9] Use of combination cytomegalovirus immune globulin plus ganciclovir for prophylaxis in CMV-seronegative liver transplant recipients of a CMV-seropositive donor organ: A multicenter, open-label study
    Snydman, DR
    Falagas, ME
    Avery, R
    Perlino, C
    Ruthazer, R
    Freeman, R
    Rohrer, R
    Fairchild, R
    O'Rourke, E
    Hibberd, P
    Werner, BG
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (04) : 2571 - 2575
  • [10] Decreased incidence of acute rejection without increased incidence of cytomegalovirus (CMV) infection in kidney transplant recipients receiving rabbit anti-thymocyte globulin without CMV prophylaxis - a cohort single-center study
    de Paula, Mayara Ivani
    Bowring, Mary Grace
    Shaffer, Ashton A.
    Garonzik-Wang, Jacqueline
    Bessa, Adrieli Barros
    Felipe, Claudia Rosso
    Cristelli, Marina Pontello
    Massie, Allan B.
    Medina-Pestana, Jose
    Segev, Dorry L.
    Tedesco-Silva, Helio
    TRANSPLANT INTERNATIONAL, 2021, 34 (02) : 339 - 352
123